Moreover, we found decreased LEF1 expression in the CMS3 and CRISA subtypes of CRC, which are characterized by KRAS mutations and in serrated adenomas, which typically harbor KRAS/Serine/Threonine-Protein Kinase B-Raf (BRAF) mutations (30, 31, 57). Here, KRAS is linked to colorectal carcinoma.